Inozyme Pharma, Inc. (INZY) Tops Q3 EPS by 5c
Tweet
Share
E-mailGet Alerts INZY Hot Sheet
Join SI Premium – FREE
Inozyme Pharma, Inc. (NASDAQ: INZY) reported Q3 EPS of ($0.39), $0.05 better than the analyst estimate of ($0.44).
For earnings history and earnings-related data on Inozyme Pharma, Inc. (INZY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Movano (MOVE) Misses Q2 EPS by 195c
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Stripe, Advent In Talks To Buy Paypal - WSJ
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
